Pfizer and Genentech Duke it Out in Court over Herceptin Biosimilar Patents Post author:Sam Post published:November 21, 2017 Post category:BioPharma Genentech is claiming that Pfizer’s proposed biosimilar infringes 40 of its patents. Source: BioSpace You Might Also Like Nordson, Pounce, Buy Pieces of Vention Medical February 20, 2017 COO and First Employee of Editas Medicine to Exit, Effective March 31 March 5, 2017 Dyadic Reports First Quarter 2017 Financial Results May 11, 2017
